Merdury Biopharmaceutical Corporation (TPEX:6932)
8.05
+0.06 (0.75%)
Mar 6, 2026, 11:25 AM CST
Revenue by Segment
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Revenue by Geography
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Source: S&P Global Market Intelligence.